Pharma-Bio Serv (PBSV) Invested Capital (2010 - 2026)

Pharma-Bio Serv's Invested Capital history runs 17 years deep, the most recent figure standing at $10.5 million for Q2 2026.

• Invested Capital for Q2 2026 came in at $10.5 million, down 13.77% year-over-year; the trailing twelve-month figure through Apr 2026 was $10.5 million (down 13.77% YoY), and the FY2025 annual result was $11.9 million, down 13.13% from the prior year.
• Invested Capital came in at $10.5 million for Q2 2026 at Pharma-Bio Serv, up from $10.2 million in the prior quarter.
• In the past five years, Invested Capital ranged from a high of $17.4 million in Q1 2022 to a low of $10.2 million in Q1 2026.
• A 5-year average of $14.2 million and a median of $14.1 million in 2024 frame the typical range for Invested Capital.
• Across the five-year window, Invested Capital sank 32.26% in 2022 and gained 0.23% in 2023, its largest moves.
• Over 5 years, Invested Capital stood at $16.6 million in 2022, then decreased by 2.6% to $16.1 million in 2023, then declined by 14.95% to $13.7 million in 2024, then retreated by 13.13% to $11.9 million in 2025, then slipped by 12.25% to $10.5 million in 2026.
• The last three Invested Capital figures came in at $10.5 million (Q2 2026), $10.2 million (Q1 2026), and $11.9 million (Q4 2025), per Business Quant data.